BDBM405183 N-(cyanomethyl)-1-[4-(6-{2-[3- (trifluoromethoxy)phenyl]acetamido} pyridazin-3-yl)butyl]-1H-1,2,3- triazole-4-carboxamide::US10344025, Example 527::US11370786, Example 527

SMILES FC(F)(F)Oc1cccc(CC(=O)Nc2ccc(CCCCn3cc(nn3)C(=O)NCC#N)nn2)c1

InChI Key InChIKey=GBEBRCDTKPPWHA-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 405183   

TargetGlutaminase kidney isoform, mitochondrial(Human)
The University of Texas Md Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM405183(N-(cyanomethyl)-1-[4-(6-{2-[3- (trifluoromethoxy)p...)
Affinity DataIC50: 14nMAssay Description:Inhibition of recombinant human GLS1 using glutamine as substrate preincubated for 10 mins followed by substrate addition and measured after 20 mins ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetGlutaminase kidney isoform, mitochondrial(Human)
The University of Texas Md Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM405183(N-(cyanomethyl)-1-[4-(6-{2-[3- (trifluoromethoxy)p...)
Affinity DataIC50: 100nMAssay Description:The inhibition of purified recombinant human GAC by varying concentrations of inhibitors is assessed via a dual-coupled enzymatic assay. The glutamat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2020
Entry Details
US Patent

TargetGlutaminase kidney isoform, mitochondrial(Human)
The University of Texas Md Anderson Cancer Center

Curated by ChEMBL
LigandPNGBDBM405183(N-(cyanomethyl)-1-[4-(6-{2-[3- (trifluoromethoxy)p...)
Affinity DataIC50: 100nMAssay Description:The inhibition of purified recombinant human GAC by varying concentrations of inhibitors is assessed via a dual-coupled enzymatic assay. The glutamat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent